Pavlović N B, Stojacnov S, Ljubenović S, Krivokapić R
Institute of Nephrology, University School of Medicine, Nish.
Srp Arh Celok Lek. 1996;124 Suppl 1:157-8.
Polycystic kidney disease is a relative contraindication for active treatment with peritoneal dialysis (PD). We have treated 10 end stage kidney disease patients with PD, 4 with intermittent PD and 6 with CAPD. PD was successful in most of these patients. The following complications recurred: a marked increase in arterial blood pressure occurred in one patient, epileptiform fits appeared three times in a patient due to hypocalcemia; renal cancer was documented in a patient after two months on PD. Our results support the view that in selected cases peritoneal dialysis could be successfully used in end-stage polycystic kidney disease.
多囊肾病是腹膜透析（PD）积极治疗的相对禁忌证。我们用PD治疗了10例终末期肾病患者，4例采用间歇性PD，6例采用持续性非卧床腹膜透析（CAPD）。PD在这些患者中的大多数取得了成功。出现了以下并发症：1例患者动脉血压显著升高；1例患者因低钙血症癫痫样发作3次；1例患者在PD治疗两个月后被诊断出肾癌。我们的结果支持这样一种观点，即在某些特定病例中，腹膜透析可成功用于终末期多囊肾病。
